Frontlight ResearchEarly access
Trial site
Rosewell Park Cancer Institute
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- Myelodysplastic syndromes2 trials
- Acute lymphoblastic leukaemia1 trial
- Aplastic anaemia1 trial
- Childhood cancers1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Hodgkin lymphoma1 trial
- Kidney cancer1 trial
- Sickle cell disease1 trial
- Phase
- Phase 21 trial
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Center for International Blood and Marrow Transplant Research1 trial
- Dana-Farber Cancer Institute1 trial
- Eisai Inc.1 trial
- Taiho Oncology, Inc.1 trial
Running trials
Enrolling by invitation
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026